Repligen Corp (RGEN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select FieldsSymbol | RGEN | BPMC | EXEL | ||
Company | Repligen Corp | Blueprint Medicines Corp | Exelixis Inc | ||
Price Information | |||||
Exchange | NASDAQ | NASDAQ | NASDAQ | ||
Open | 120.86 | 108.47 | 21.96 | ||
High | 121.81 | 111.99 | 22.17 | ||
Low | 119.76 | 108.33 | 21.87 | ||
Last | 120.08 | 111.70 | 22.10 | ||
Change | -0.69 | +2.67 | +0.14 | ||
% Change | -0.57% | +2.45% | +0.64% | ||
Volume | 577,569 | 343,163 | 630,363 | ||
20-Day Average Volume | 942,263 | 602,873 | 1,592,903 | ||
Previous Close | 120.77 | 109.03 | 21.96 | ||
Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
Has Options | Yes | Yes | Yes | ||
Technicals | |||||
20-Day Moving Average | 128.70 | 106.42 | 22.08 | ||
20-Day Raw Stochastic | 16.24% | 97.44% | 54.01% | ||
20-Day Relative Strength | 29.84% | 60.95% | 51.48% | ||
Weighted Alpha | -31.42 | +100.37 | +10.31 | ||
Today's Opinion | 88% Sell | 100% Buy | 8% Buy | ||
Previous Opinion | 88% Sell | 100% Buy | 24% Sell | ||
Last Month's Opinion | 88% Sell | 88% Buy | 16% Sell | ||
Performance | |||||
5-Days | |||||
%Chg | -5.14% since 06/27/24 | +2.93% since 06/27/24 | -1.91% since 06/27/24 | ||
Low | 119.76 on 07/05/24 | 105.52 on 06/28/24 | 21.82 on 07/03/24 | ||
High | 128.46 on 06/28/24 | 111.99 on 07/05/24 | 22.73 on 07/01/24 | ||
1-Month | |||||
%Chg | -20.32% since 06/05/24 | +5.56% since 06/05/24 | +0.64% since 06/05/24 | ||
Low | 113.50 on 06/20/24 | 100.67 on 06/10/24 | 21.36 on 06/20/24 | ||
High | 154.02 on 06/06/24 | 111.99 on 07/05/24 | 22.73 on 07/01/24 | ||
3-Month | |||||
%Chg | -30.91% since 04/05/24 | +21.88% since 04/05/24 | -4.49% since 04/05/24 | ||
Low | 113.50 on 06/20/24 | 84.33 on 04/15/24 | 20.14 on 05/29/24 | ||
High | 182.21 on 04/09/24 | 111.99 on 07/05/24 | 23.89 on 04/29/24 | ||
6-Month | |||||
%Chg | -30.04% since 01/05/24 | +34.63% since 01/05/24 | -4.91% since 01/05/24 | ||
Low | 113.50 on 06/20/24 | 72.24 on 02/14/24 | 19.20 on 01/08/24 | ||
High | 211.13 on 02/16/24 | 111.99 on 07/05/24 | 24.07 on 03/21/24 | ||
Key Statistics | |||||
Market Capitalization, $K | 6,748,143 | 6,827,131 | 6,658,272 | ||
Shares Outstanding, K | 55,876 | 62,617 | 303,200 | ||
Annual Sales | 638,760,000 | 249,380,000 | 1,830,210,000 | ||
Annual Net Income | 41,580,000 | -506,980,000 | 207,770,000 | ||
Last Quarter Sales | 151,350,000 | 96,120,000 | 425,230,000 | ||
Last Quarter Net Income | 2,090,000 | 89,140,000 | 37,320,000 | ||
60-Month Beta | 0.95 | 0.63 | 0.54 | ||
Per-Share Information | |||||
Most Recent Earnings | 0.28 on 05/01/24 | -1.32 on 05/02/24 | 0.17 on 04/30/24 | ||
Latest Earnings Date | 08/07/24 | 08/07/24 | 08/06/24 | ||
Most Recent Dividend | N/A | N/A | N/A | ||
Next Ex-Dividends Date | N/A | N/A | N/A | ||
Ratios | |||||
Price/Earnings ttm | 87.69 | 0.00 | 34.61 |